Rudolf Benz

745 total citations
36 papers, 418 citations indexed

About

Rudolf Benz is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Rudolf Benz has authored 36 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Rudolf Benz's work include Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Rudolf Benz is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Rudolf Benz collaborates with scholars based in Switzerland, Germany and United Kingdom. Rudolf Benz's co-authors include Georg Stüssi, Urs Schanz, Jörg D. Seebach, Marco Maggiorini, W. H. Zachariasen, Jörg Fehr, Thierry Buclin, Gabriela M. Baerlocher, Nathan Cantoni and Michael Gregor and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

In The Last Decade

Rudolf Benz

33 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rudolf Benz Switzerland 11 188 126 76 65 59 36 418
Takahiro Yamauchi Japan 13 104 0.6× 82 0.7× 99 1.3× 64 1.0× 106 1.8× 91 542
Anna Pawłowska United States 11 125 0.7× 65 0.5× 95 1.3× 60 0.9× 33 0.6× 44 465
Kenneth Washenik United States 5 132 0.7× 59 0.5× 52 0.7× 30 0.5× 47 0.8× 7 409
D Pei United States 7 215 1.1× 73 0.6× 113 1.5× 28 0.4× 35 0.6× 7 729
E Pozzoli Italy 13 248 1.3× 104 0.8× 113 1.5× 90 1.4× 71 1.2× 43 585
Wen‐Li Hwang Taiwan 12 150 0.8× 50 0.4× 72 0.9× 32 0.5× 70 1.2× 30 359
Yoshiki Terada Japan 11 139 0.7× 53 0.4× 196 2.6× 46 0.7× 91 1.5× 42 573
Seth E. Karol United States 13 222 1.2× 45 0.4× 152 2.0× 27 0.4× 33 0.6× 73 635
Jennifer Holter‐Chakrabarty United States 12 100 0.5× 44 0.3× 68 0.9× 39 0.6× 22 0.4× 49 339
Mika Nakamae Japan 12 280 1.5× 62 0.5× 204 2.7× 66 1.0× 46 0.8× 73 669

Countries citing papers authored by Rudolf Benz

Since Specialization
Citations

This map shows the geographic impact of Rudolf Benz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Benz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Benz more than expected).

Fields of papers citing papers by Rudolf Benz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Benz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Benz. The network helps show where Rudolf Benz may publish in the future.

Co-authorship network of co-authors of Rudolf Benz

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Benz. A scholar is included among the top collaborators of Rudolf Benz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Benz. Rudolf Benz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Condoluci, Adalgisa, Ilaria Romano, Daniel Dietrich, et al.. (2025). Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial. Blood. 145(22). 2587–2598. 2 indexed citations
2.
Volken, Thomas, Sergio Cogliatti, Thomas Lehmann, et al.. (2023). CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study. Cancers. 15(5). 1479–1479. 2 indexed citations
3.
Volken, Thomas, Sergio Cogliatti, Thomas Lehmann, et al.. (2023). Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers. 15(19). 4698–4698. 1 indexed citations
4.
Daskalakis, Michael, Naomi Porret, Ramanjaneyulu Allam, et al.. (2021). Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers. 13(13). 3296–3296. 4 indexed citations
5.
Schoenenberger, Andreas W., et al.. (2021). Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine. HemaSphere. 5(8). e618–e618. 13 indexed citations
6.
Wilk, C. Matthias, Rudolf Benz, Michael Daskalakis, et al.. (2020). Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement. International Journal of Environmental Research and Public Health. 17(24). 9562–9562. 3 indexed citations
7.
Daskalakis, Michael, Anita Feller, Ulrike Bacher, et al.. (2019). Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries. Cancer Epidemiology. 59. 51–57. 10 indexed citations
8.
9.
Goede, Jeroen S., et al.. (2017). sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy. Annals of Hematology. 96(5). 757–763. 1 indexed citations
10.
Bonadies, Nicolas, Anita Feller, Alicia Rovó, et al.. (2017). Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiology. 46. 85–92. 24 indexed citations
11.
Benz, Rudolf, Jens Bremerich, Nathan Cantoni, et al.. (2017). Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload. Swiss Medical Weekly. 147(4546). w14550–w14550. 11 indexed citations
12.
Benz, Rudolf, et al.. (2015). Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study. Clinical Lymphoma Myeloma & Leukemia. 15(12). 811–815. 2 indexed citations
13.
Urosevic‐Maiwald, Mirjana, Stephan Nobbe, Katrin Kerl, & Rudolf Benz. (2014). Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment or disease-related?. Dermatology Online Journal. 20(3). 1 indexed citations
14.
Gotta, Verena, Nicolas Widmer, Laurent A. Décosterd, et al.. (2014). Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial. Cancer Chemotherapy and Pharmacology. 74(6). 1307–1319. 66 indexed citations
15.
Benz, Rudolf, Urs Schanz, Marco Maggiorini, Jörg D. Seebach, & Georg Stüssi. (2013). Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplantation. 49(1). 62–65. 54 indexed citations
16.
Benz, Rudolf, et al.. (2009). When a clear crystal makes a case crystal clear. Practical Neurology. 9(6). 345–346.
17.
Benz, Rudolf, Jeroen S. Goede, V. Parlier, et al.. (2008). G-CSF-induced remission in two cases of acute myeloid leukemia. Leukemia Research. 32(7). 1148–1152. 2 indexed citations
18.
Benz, Rudolf, et al.. (2008). Long‐term follow‐up of interferon‐alpha induction and low‐dose maintenance therapy in hairy cell leukemia. European Journal Of Haematology. 82(3). 194–200. 23 indexed citations
19.
Goede, Jeroen S., Rudolf Benz, J Fehr, Klaus Schwarz, & H. Heimpel. (2006). Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy. Annals of Hematology. 85(9). 591–595. 13 indexed citations
20.
Benz, Rudolf & W. H. Zachariasen. (1969). Crystal structure of the compounds U2N2X and Th2(N,O)2 with X = P, S, As and Se. Acta Crystallographica Section B. 25(2). 294–296. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Yamauchi Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Kenneth Washenik Breakdown of academic impact, for papers by D Pei Breakdown of academic impact, for papers by E Pozzoli Breakdown of academic impact, for papers by Wen‐Li Hwang Breakdown of academic impact, for papers by Yoshiki Terada Breakdown of academic impact, for papers by Seth E. Karol Breakdown of academic impact, for papers by Jennifer Holter‐Chakrabarty Breakdown of academic impact, for papers by Mika Nakamae
Rankless by CCL
2026